158 related articles for article (PubMed ID: 10092105)
41. The N terminus of mannose 6-phosphate/insulin-like growth factor 2 receptor in regulation of fibrinolysis and cell migration.
Leksa V; Godár S; Cebecauer M; Hilgert I; Breuss J; Weidle UH; Horejsí V; Binder BR; Stockinger H
J Biol Chem; 2002 Oct; 277(43):40575-82. PubMed ID: 12189157
[TBL] [Abstract][Full Text] [Related]
42. High-affinity antibodies from hen's-egg yolks against human mannose-6-phosphate/insulin-like growth-factor-II receptor (M6P/IGFII-R): characterization and potential use in clinical cancer studies.
Lemamy GJ; Roger P; Mani JC; Robert M; Rochefort H; Brouillet JP
Int J Cancer; 1999 Mar; 80(6):896-902. PubMed ID: 10074924
[TBL] [Abstract][Full Text] [Related]
43. Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36.
Yehualaeshet T; O'Connor R; Green-Johnson J; Mai S; Silverstein R; Murphy-Ullrich JE; Khalil N
Am J Pathol; 1999 Sep; 155(3):841-51. PubMed ID: 10487979
[TBL] [Abstract][Full Text] [Related]
44. Regulation of macrophage migration by a novel plasminogen receptor Plg-R KT.
Lighvani S; Baik N; Diggs JE; Khaldoyanidi S; Parmer RJ; Miles LA
Blood; 2011 Nov; 118(20):5622-30. PubMed ID: 21940822
[TBL] [Abstract][Full Text] [Related]
45. Local activation of TGF-beta1 at endometriosis sites.
Komiyama S; Aoki D; Komiyama M; Nozawa S
J Reprod Med; 2007 Apr; 52(4):306-12. PubMed ID: 17506371
[TBL] [Abstract][Full Text] [Related]
46. SMAD3 is essential for transforming growth factor-β1-induced urokinase type plasminogen activator expression and migration in transformed keratinocytes.
Kocic J; Bugarski D; Santibanez JF
Eur J Cancer; 2012 Jul; 48(10):1550-7. PubMed ID: 21798735
[TBL] [Abstract][Full Text] [Related]
47. Correlation between mannose-6-phosphate/IGFII receptor and cathepsin D RNA levels by in situ hybridization in benign and malignant mammary tumors.
Zhao Y; Escot C; Maudelonde T; Puech C; Rouanet P; Rochefort H
Cancer Res; 1993 Jun; 53(12):2901-5. PubMed ID: 7684951
[TBL] [Abstract][Full Text] [Related]
48. Urokinase expression and binding activity associated with the transforming growth factor beta1-induced migratory and invasive phenotype of mouse epidermal keratinocytes.
Santibáñez JF; Frontelo P; Iglesias M; Martínez J; Quintanilla M
J Cell Biochem; 1999 Jul; 74(1):61-73. PubMed ID: 10381262
[TBL] [Abstract][Full Text] [Related]
49. Assembly of urokinase receptor-mediated plasminogen activation complexes involves direct, non-active-site interactions between urokinase and plasminogen.
Ellis V; Whawell SA; Werner F; Deadman JJ
Biochemistry; 1999 Jan; 38(2):651-9. PubMed ID: 9888805
[TBL] [Abstract][Full Text] [Related]
50. Proteomics-based discovery of a novel, structurally unique, and developmentally regulated plasminogen receptor, Plg-RKT, a major regulator of cell surface plasminogen activation.
Andronicos NM; Chen EI; Baik N; Bai H; Parmer CM; Kiosses WB; Kamps MP; Yates JR; Parmer RJ; Miles LA
Blood; 2010 Feb; 115(7):1319-30. PubMed ID: 19897580
[TBL] [Abstract][Full Text] [Related]
51. Modulation of urokinase-type plasminogen activator by transforming growth factor beta1 in acetaldehyde-activated hepatic stellate cells.
Pérez-Liz G; Flores-Hernández J; Arias-Montaño JA; Reyes-Esparza JA; Rodríguez-Fragoso L
Pharmacology; 2005 Jan; 73(1):23-30. PubMed ID: 15452360
[TBL] [Abstract][Full Text] [Related]
52. Modulation of transforming growth factor beta receptor levels on microvascular endothelial cells during in vitro angiogenesis.
Sankar S; Mahooti-Brooks N; Bensen L; McCarthy TL; Centrella M; Madri JA
J Clin Invest; 1996 Mar; 97(6):1436-46. PubMed ID: 8617876
[TBL] [Abstract][Full Text] [Related]
53. Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity.
Stillfried GE; Saunders DN; Ranson M
Breast Cancer Res; 2007; 9(1):R14. PubMed ID: 17257442
[TBL] [Abstract][Full Text] [Related]
54. Plasmin abrogates alpha v beta 5-mediated adhesion of a human keratinocyte cell line (HaCaT) to vitronectin.
Reinartz J; Schäfer B; Batrla R; Klein CE; Kramer MD
Exp Cell Res; 1995 Oct; 220(2):274-82. PubMed ID: 7556434
[TBL] [Abstract][Full Text] [Related]
55. Induction of the plasminogen activator system by mechanical stimulation of human bronchial epithelial cells.
Chu EK; Cheng J; Foley JS; Mecham BH; Owen CA; Haley KJ; Mariani TJ; Kohane IS; Tschumperlin DJ; Drazen JM
Am J Respir Cell Mol Biol; 2006 Dec; 35(6):628-38. PubMed ID: 16794260
[TBL] [Abstract][Full Text] [Related]
56. Urokinase/urokinase receptor system: internalization/degradation of urokinase-serpin complexes: mechanism and regulation.
Conese M; Blasi F
Biol Chem Hoppe Seyler; 1995 Mar; 376(3):143-55. PubMed ID: 7612191
[TBL] [Abstract][Full Text] [Related]
57. Role of urokinase in the activation of macrophage-associated TGF-beta in silica-induced lung fibrosis.
Matrat M; Lardot C; Huaux F; Broeckaert F; Lison D
J Toxicol Environ Health A; 1998 Nov; 55(5):359-71. PubMed ID: 9829559
[TBL] [Abstract][Full Text] [Related]
58. Mechanism of retinoid-induced activation of latent transforming growth factor-beta in bovine endothelial cells.
Kojima S; Rifkin DB
J Cell Physiol; 1993 May; 155(2):323-32. PubMed ID: 8482724
[TBL] [Abstract][Full Text] [Related]
59. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
Plesner T; Behrendt N; Ploug M
Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652
[TBL] [Abstract][Full Text] [Related]
60. Active transforming growth factor-beta in human melanoma cell lines: no evidence for plasmin-related activation of latent TGF-beta.
Bizik J; Felnerova D; Grofova M; Vaheri A
J Cell Biochem; 1996 Jul; 62(1):113-22. PubMed ID: 8836880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
